As a critical hallmark of NAFLD, immune cells typically increase at the transition from steatosis to NASH, leading to fibrosis through the release of cytokines like IL-6, IL-1β, IL-17, IL-22, TGF-β, and tumor necrosis factor-α (TNF-α). Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.